The DOI matches its Crossref record; 296 of the 296 references it cites were found in a registry or an index.
Lipid alterations in chronic liver disease and liver cancer
Open accessAbstract
Lipids are a complex and diverse group of molecules with crucial roles in many physiological processes, as well as in the onset, progression, and maintenance of cancers. Fatty acids and cholesterol are the building blocks of lipids, orchestrating these crucial metabolic processes. In the liver, lipid alterations are prevalent as a cause and consequence of chronic hepatitis B and C virus infections, alcoholic hepatitis, and non-alcoholic fatty liver disease and steatohepatitis. Recent developments in lipidomics have also revealed that dynamic changes in triacylglycerols, phospholipids, sphingolipids, ceramides, fatty acids, and cholesterol are involved in the development and progression of primary liver cancer. Accordingly, the transcriptional landscape of lipid metabolism suggests a carcinogenic role of increasing fatty acids and sterol synthesis. However, limited mechanistic insights into the complex nature of the hepatic lipidome have so far hindered the development of effective therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2019) · International Journal of Cancer · doi:10.1002/ijc.31937 · Cited by 7,553
Membrane lipids: where they are and how they behave
van Meer, G., Voelker, D. R., & Feigenson, G. W. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2330 · Cited by 7,157
Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094
Llovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., & Finn, R. S. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00240-3 · Cited by 7,055
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
The metabolism of tumors in the body
Warburg, O., Wind, F., & Negelein, E. (1927) · Journal of General Physiology · doi:10.1085/jgp.8.6.519 · Cited by 4,416
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Ally, A., Balasundaram, M., Carlsen, R., Chuah, E., Clarke, A., Dhalla, N., Holt, R. A., Jones, S. J. M., Lee, D., Ma, Y., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.046 · Cited by 2,490
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Banales, J. M., Marin, J. J. G., Lamarca, A., Rodrigues, P. M., Khan, S. A., Roberts, L. R., Cardinale, V., Carpino, G., Andersen, J. B., Braconi, C., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0310-z · Cited by 2,411
Self-citationBrown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., Muir, A. I., Wigglesworth, M. J., Kinghorn, I., Fraser, N. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211609200 · Cited by 2,409
Estes, C., Razavi, H., Loomba, R., Younossi, Z., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29466 · Cited by 2,399
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Nieman, K. M., Kenny, H. A., Penicka, C. V., Ladanyi, A., Buell-Gutbrod, R., Zillhardt, M. R., Romero, I. L., Carey, M. S., Mills, G. B., Hotamisligil, G. S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2492 · Cited by 2,279
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237
Forman, B. M., Chen, J., & Evans, R. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4312 · Cited by 2,116
Global Burden of Disease Liver Cancer Collaboration, Akinyemiju, T., Abera, S., Ahmed, M., Alam, N., Alemayohu, M. A., Allen, C., Al-Raddadi, R., Alvis-Guzman, N., Amoako, Y., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3055 · Cited by 1,987
A comprehensive classification system for lipids
Fahy, E., Subramaniam, S., Brown, H. A., Glass, C. K., Merrill, A. H., Murphy, R. C., Raetz, C. R. H., Russell, D. W., Seyama, Y., Shaw, W., et al. (2005) · Journal of Lipid Research · doi:10.1194/jlr.e400004-jlr200 · Cited by 1,699
A lipidomic analysis of nonalcoholic fatty liver disease
Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M. J., & Sanyal, A. J. (2007) · Hepatology · doi:10.1002/hep.21763 · Cited by 1,338
Cholangiocarcinoma: Thirty-one-Year Experience With 564 Patients at a Single Institution
DeOliveira, M. L., Cunningham, S. C., Cameron, J. L., Kamangar, F., Winter, J. M., Lillemoe, K. D., Choti, M. A., Yeo, C. J., & Schulick, R. D. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000251366.62632.d3 · Cited by 1,300
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Pfister, D., Núñez, N. G., Pinyol, R., Govaere, O., Pinter, M., Szydlowska, M., Gupta, R., Qiu, M., Deczkowska, A., Weiner, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03362-0 · Cited by 1,294
Wymann, M. P., & Schneiter, R. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2335 · Cited by 1,291
The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice
Moriya, K., Fujie, H., Shintani, Y., Yotsuyanagi, H., Tsutsumi, T., Ishibashi, K., Matsuura, Y., Kimura, S., Miyamura, T., & Koike, K. (1998) · Nature Medicine · doi:10.1038/2053 · Cited by 1,206
Cholangiocarcinoma: A Spectrum of Intrahepatic, Perihilar, and Distal Tumors
Nakeeb, A., Pitt, H. A., Sohn, T. A., Coleman, J., Abrams, R. A., Piantadosi, S., Hruban, R. H., Lillemoe, K. D., Yeo, C. J., & Cameron, J. L. (1996) · Annals of Surgery · doi:10.1097/00000658-199610000-00005 · Cited by 1,187
Ratziu, V., Harrison, S. A., Francque, S., Bedossa, P., Lehert, P., Serfaty, L., Romero-Gomez, M., Boursier, J., Abdelmalek, M., Caldwell, S., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.038 · Cited by 1,035
Chávez-Talavera, O., Tailleux, A., Lefebvre, P., & Staels, B. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.055 · Cited by 970
(2011) · Hepatogastroenterology · doi:10.5754/hge11427 · Cited by 953
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
Kanwal, F., Kramer, J., Asch, S. M., Chayanupatkul, M., Cao, Y., & El-Serag, H. B. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.06.012 · Cited by 931
Han, X., & Gross, R. W. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r300004-jlr200 · Cited by 914
Brindley, P. J., Bachini, M., Ilyas, S. I., Khan, S. A., Loukas, A., Sirica, A. E., Teh, B. T., Wongkham, S., & Gores, G. J. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00300-2 · Cited by 841
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
Francque, S. M., Bedossa, P., Ratziu, V., Anstee, Q. M., Bugianesi, E., Sanyal, A. J., Loomba, R., Harrison, S. A., Balabanska, R., Mateva, L., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2036205 · Cited by 801
Bugianesi, E., Gastaldelli, A., Vanni, E., Gambino, R., Cassader, M., Baldi, S., Ponti, V., Pagano, G., Ferrannini, E., & Rizzetto, M. (2005) · Diabetologia · doi:10.1007/s00125-005-1682-x · Cited by 770
NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis
Ma, C., Kesarwala, A. H., Eggert, T., Medina-Echeverz, J., Kleiner, D. E., Jin, P., Stroncek, D. F., Terabe, M., Kapoor, V., ElGindi, M., et al. (2016) · Nature · doi:10.1038/nature16969 · Cited by 766 · cited 1×
“This LA-mediated loss of intrahepatic CD4 T cells, but not CD8 T lymphocytes, results in HCC progression.(97) On a background of NASH, CD8 T cells promote the incidence of murine HCC because of impaired tumour surveillance and increased tissue damage by lymphocytes.”
BackgroundThe Role of Orphan Nuclear Receptors in the Regulation of Cholesterol Homeostasis
Repa, J. J., & Mangelsdorf, D. J. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.459 · Cited by 759
Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance
Kim, J. K., Fillmore, J. J., Chen, Y., Yu, C., Moore, I. K., Pypaert, M., Lutz, E. P., Kako, Y., Velez-Carrasco, W., Goldberg, I. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121164498 · Cited by 753
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
Jiang, C., Xie, C., Li, F., Zhang, L., Nichols, R. G., Krausz, K. W., Cai, J., Qi, Y., Fang, Z.-Z., Takahashi, S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76738 · Cited by 693
Transcriptional regulation of hepatic lipogenesis
Wang, Y., Viscarra, J., Kim, S.-J., & Sul, H. S. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4074 · Cited by 646
The immunological and metabolic landscape in primary and metastatic liver cancer
Li, X., Ramadori, P., Pfister, D., Seehawer, M., Zender, L., & Heikenwalder, M. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00383-9 · Cited by 616
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles
Farshidfar, F., Zheng, S., Gingras, M.-C., Newton, Y., Shih, J., Robertson, A. G., Hinoue, T., Hoadley, K. A., Gibb, E. A., Roszik, J., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.033 · Cited by 610
Self-citationCalvisi, D. F., Wang, C., Ho, C., Ladu, S., Lee, S. A., Mattu, S., Destefanis, G., Delogu, S., Zimmermann, A., Ericsson, J., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.12.006 · Cited by 595
Effects of Prolonged Ethanol Intake: Production of Fatty Liver Despite Adequate Diets*
Lieber, C. S., Jones, D. P., & DeCarli, L. M. (1965) · Journal of Clinical Investigation · doi:10.1172/jci105200 · Cited by 589
Tsuchida, T., Lee, Y. A., Fujiwara, N., Ybanez, M., Allen, B., Martins, S., Fiel, M. I., Goossens, N., Chou, H.-I., Hoshida, Y., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.011 · Cited by 583
Advances in molecular classification and precision oncology in hepatocellular carcinoma
Rebouissou, S., & Nault, J.-C. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.017 · Cited by 575
You, M., Fischer, M., Deeg, M. A., & Crabb, D. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202411200 · Cited by 543
Nilsson, N. E., Kotarsky, K., Owman, C., & Olde, B. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00488-1 · Cited by 540
Ji, C., & Kaplowitz, N. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00276-2 · Cited by 539
Fatty acid oxidation: An emerging facet of metabolic transformation in cancer
Ma, Y., Temkin, S. M., Hawkridge, A. M., Guo, C., Wang, W., Wang, X.-Y., & Fang, X. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.08.006 · Cited by 531
van der Windt, D. J., Sud, V., Zhang, H., Varley, P. R., Goswami, J., Yazdani, H. O., Tohme, S., Loughran, P., O'Doherty, R. M., Minervini, M. I., et al. (2018) · Hepatology · doi:10.1002/hep.29914 · Cited by 477
Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity
Vriens, K., Christen, S., Parik, S., Broekaert, D., Yoshinaga, K., Talebi, A., Dehairs, J., Escalona-Noguero, C., Schmieder, R., Cornfield, T., et al. (2019) · Nature · doi:10.1038/s41586-019-0904-1 · Cited by 477
Luukkonen, P. K., Zhou, Y., Sädevirta, S., Leivonen, M., Arola, J., Orešič, M., Hyötyläinen, T., & Yki-Järvinen, H. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.002 · Cited by 461
Singh, S., Singh, P. P., Singh, A. G., Murad, M. H., & Sanchez, W. (2013) · Gastroenterology · doi:10.1053/j.gastro.2012.10.005 · Cited by 452
Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests
Masoodi, M., Gastaldelli, A., Hyötyläinen, T., Arretxe, E., Alonso, C., Gaggini, M., Brosnan, J., Anstee, Q. M., Millet, O., Ortiz, P., et al. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00502-9 · Cited by 451
Targeting a ceramide double bond improves insulin resistance and hepatic steatosis
Chaurasia, B., Tippetts, T. S., Mayoral Monibas, R., Liu, J., Li, Y., Wang, L., Wilkerson, J. L., Sweeney, C. R., Pereira, R. F., Sumida, D. H., et al. (2019) · Science · doi:10.1126/science.aav3722 · Cited by 450
Diraison, F., Moulin, P., & Beylot, M. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70061-7 · Cited by 435
p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression
Moon, S.-H., Huang, C.-H., Houlihan, S. L., Regunath, K., Freed-Pastor, W. A., Morris, J. P., Tschaharganeh, D. F., Kastenhuber, E. R., Barsotti, A. M., Culp-Hill, R., et al. (2019) · Cell · doi:10.1016/j.cell.2018.11.011 · Cited by 435
Baek, A. E., Yu, Y.-R. A., He, S., Wardell, S. E., Chang, C.-Y., Kwon, S., Pillai, R. V., McDowell, H. B., Thompson, J. W., Dubois, L. G., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00910-z · Cited by 427
Puri, P., Daita, K., Joyce, A., Mirshahi, F., Santhekadur, P. K., Cazanave, S., Luketic, V. A., Siddiqui, M. S., Boyett, S., Min, H., et al. (2018) · Hepatology · doi:10.1002/hep.29359 · Cited by 426
Kim, C.-W., Addy, C., Kusunoki, J., Anderson, N. N., Deja, S., Fu, X., Burgess, S. C., Li, C., Ruddy, M., Chakravarthy, M., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.07.009 · Cited by 419
Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue Metabolomics
Huang, Q., Tan, Y., Yin, P., Ye, G., Gao, P., Lu, X., Wang, H., & Xu, G. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0308 · Cited by 414
Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis
Wang, X., Zheng, Z., Caviglia, J. M., Corey, K. E., Herfel, T. M., Cai, B., Masia, R., Chung, R. T., Lefkowitch, J. H., Schwabe, R. F., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.016 · Cited by 413 · cited 3×
“Either inhibition of ACC itself or deletion of AMPK-targeted ACC phosphorylation sites lead to a significant decreased tumour burden and attenuated DNL in diethylnitrosamine-induced HCC.208 Also, in vitro, these modifications result in decreased proliferation and 8vol. 4 j 100479 viability of HCC cells.17 Accordingly,…”
BackgroundImaging of Lipid Biosynthesis: How a Neutral Lipid Enters Lipid Droplets
Kuerschner, L., Moessinger, C., & Thiele, C. (2008) · Traffic · doi:10.1111/j.1600-0854.2007.00689.x · Cited by 411
Lally, J. S. V., Ghoshal, S., DePeralta, D. K., Moaven, O., Wei, L., Masia, R., Erstad, D. J., Fujiwara, N., Leong, V., Houde, V. P., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.08.020 · Cited by 410
mTORC2 Promotes Tumorigenesis via Lipid Synthesis
Guri, Y., Colombi, M., Dazert, E., Hindupur, S. K., Roszik, J., Moes, S., Jenoe, P., Heim, M. H., Riezman, I., Riezman, H., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.11.011 · Cited by 407
27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen
Umetani, M., Domoto, H., Gormley, A. K., Yuhanna, I. S., Cummins, C. L., Javitt, N. B., Korach, K. S., Shaul, P. W., & Mangelsdorf, D. J. (2007) · Nature Medicine · doi:10.1038/nm1641 · Cited by 396
Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease
Mouzaki, M., Wang, A. Y., Bandsma, R., Comelli, E. M., Arendt, B. M., Zhang, L., Fung, S., Fischer, S. E., McGilvray, I. G., & Allard, J. P. (2016) · PLOS ONE · doi:10.1371/journal.pone.0151829 · Cited by 385
Biomarkers of NAFLD progression: a lipidomics approach to an epidemic
Gorden, D. L., Myers, D. S., Ivanova, P. T., Fahy, E., Maurya, M. R., Gupta, S., Min, J., Spann, N. J., McDonald, J. G., Kelly, S. L., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.p056002 · Cited by 372
WNT/β-catenin signaling in the development of liver cancers
He, S., & Tang, S. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110851 · Cited by 351
Xia, J. Y., Holland, W. L., Kusminski, C. M., Sun, K., Sharma, A. X., Pearson, M. J., Sifuentes, A. J., McDonald, J. G., Gordillo, R., & Scherer, P. E. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.06.007 · Cited by 348
Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers
Peng, X., Chen, Z., Farshidfar, F., Xu, X., Lorenzi, P. L., Wang, Y., Cheng, F., Tan, L., Mojumdar, K., Du, D., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.077 · Cited by 341
Nath, A., Li, I., Roberts, L. R., & Chan, C. (2015) · Scientific Reports · doi:10.1038/srep14752 · Cited by 338
SLC27 fatty acid transport proteins
Anderson, C. M., & Stahl, A. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.07.010 · Cited by 336
Top-Down Lipidomics Reveals Ether Lipid Deficiency in Blood Plasma of Hypertensive Patients
Graessler, J., Schwudke, D., Schwarz, P. E. H., Herzog, R., Shevchenko, A., & Bornstein, S. R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006261 · Cited by 323
27-Hydroxycholesterol Is an Endogenous Selective Estrogen Receptor Modulator
DuSell, C. D., Umetani, M., Shaul, P. W., Mangelsdorf, D. J., & McDonnell, D. P. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0383 · Cited by 301
Apostolopoulou, M., Gordillo, R., Koliaki, C., Gancheva, S., Jelenik, T., De Filippo, E., Herder, C., Markgraf, D., Jankowiak, F., Esposito, I., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1318 · Cited by 284
Accumulation of raft lipids in T‐cell plasma membrane domains engaged in TCR signalling
Zech, T., Ejsing, C. S., Gaus, K., de Wet, B., Shevchenko, A., Simons, K., & Harder, T. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.6 · Cited by 283
Doege, H., Baillie, R. A., Ortegon, A. M., Tsang, B., Wu, Q., Punreddy, S., Hirsch, D., Watson, N., Gimeno, R. E., & Stahl, A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.006 · Cited by 279
Patterson, A. D., Maurhofer, O., Beyoğlu, D., Lanz, C., Krausz, K. W., Pabst, T., Gonzalez, F. J., Dufour, J.-F., & Idle, J. R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0885 · Cited by 268
Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target
Liu, D., Wong, C. C., Fu, L., Chen, H., Zhao, L., Li, C., Zhou, Y., Zhang, Y., Xu, W., Yang, Y., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aap9840 · Cited by 257
FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase
Falcon, A., Doege, H., Fluitt, A., Tsang, B., Watson, N., Kay, M. A., & Stahl, A. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00226.2010 · Cited by 249
Oxysterols are agonist ligands of RORγt and drive Th17 cell differentiation
Soroosh, P., Wu, J., Xue, X., Song, J., Sutton, S. W., Sablad, M., Yu, J., Nelen, M. I., Liu, X., Castro, G., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322807111 · Cited by 248
Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma
Yahagi, N., Shimano, H., Hasegawa, K., Ohashi, K., Matsuzaka, T., Najima, Y., Sekiya, M., Tomita, S., Okazaki, H., Tamura, Y., et al. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.037 · Cited by 248
Kotronen, A., Seppänen-Laakso, T., Westerbacka, J., Kiviluoto, T., Arola, J., Ruskeepää, A.-L., Orešič, M., & Yki-Järvinen, H. (2009) · Diabetes · doi:10.2337/db08-1074 · Cited by 245
Metabolic rearrangements in primary liver cancers: cause and consequences
Satriano, L., Lewinska, M., Rodrigues, P. M., Banales, J. M., & Andersen, J. B. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0217-8 · Cited by 243
Self-citationGeidl-Flueck, B., Hochuli, M., Németh, Á., Eberl, A., Derron, N., Köfeler, H. C., Tappy, L., Berneis, K., Spinas, G. A., & Gerber, P. A. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.02.027 · Cited by 238
Budhu, A., Roessler, S., Zhao, X., Yu, Z., Forgues, M., Ji, J., Karoly, E., Qin, L., Ye, Q., Jia, H., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.054 · Cited by 238
Machado, M. V., Oliveira, A. G., & Cortez‐Pinto, H. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06801.x · Cited by 233
Bates, J., Vijayakumar, A., Ghoshal, S., Marchand, B., Yi, S., Kornyeyev, D., Zagorska, A., Hollenback, D., Walker, K., Liu, K., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.037 · Cited by 230
Feng, J., Dai, W., Mao, Y., Wu, L., Li, J., Chen, K., Yu, Q., Kong, R., Li, S., Zhang, J., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-1528-x · Cited by 227
Chronic Alcohol Exposure Stimulates Adipose Tissue Lipolysis in Mice
Zhong, W., Zhao, Y., Tang, Y., Wei, X., Shi, X., Sun, W., Sun, X., Yin, X., Sun, X., Kim, S., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.11.017 · Cited by 226
Luo, X., Zheng, E., Wei, L., Zeng, H., Qin, H., Zhang, X., Liao, M., Chen, L., Zhao, L., Ruan, X. Z., et al. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03596-w · Cited by 224
Liang, J. Q., Teoh, N., Xu, L., Pok, S., Li, X., Chu, E. S. H., Chiu, J., Dong, L., Arfianti, E., Haigh, W. G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06931-6 · Cited by 222
Loomba, R., Mohseni, R., Lucas, K. J., Gutierrez, J. A., Perry, R. G., Trotter, J. F., Rahimi, R. S., Harrison, S. A., Ajmera, V., Wayne, J. D., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.07.025 · Cited by 220
p53 Activation in Adipocytes of Obese Mice
Yahagi, N., Shimano, H., Matsuzaka, T., Najima, Y., Sekiya, M., Nakagawa, Y., Ide, T., Tomita, S., Okazaki, H., Tamura, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302364200 · Cited by 220
Rates of sterol synthesis and uptake in the major organs of the rat in vivo.
Turley, S. D., Andersen, J. M., & Dietschy, J. M. (1981) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37366-1 · Cited by 220
Self-citationFujiwara, N., Nakagawa, H., Enooku, K., Kudo, Y., Hayata, Y., Nakatsuka, T., Tanaka, Y., Tateishi, R., Hikiba, Y., Misumi, K., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315193 · Cited by 220
Lawitz, E. J., Coste, A., Poordad, F., Alkhouri, N., Loo, N., McColgan, B. J., Tarrant, J. M., Nguyen, T., Han, L., Chung, C., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.04.042 · Cited by 217
Bile acid levels are increased in the liver of patients with steatohepatitis
Aranha, M. M., Cortez-Pinto, H., Costa, A., da Silva, I. B. M., Camilo, M. E., de Moura, M. C., & Rodrigues, C. M. P. (2008) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3282f4710a · Cited by 211
Qin, W.-H., Yang, Z.-S., Li, M., Chen, Y., Zhao, X.-F., Qin, Y.-Y., Song, J.-Q., Wang, B.-B., Yuan, B., Cui, X.-L., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.028 · Cited by 209
Wu, H., Ng, R., Chen, X., Steer, C. J., & Song, G. (2016) · Gut · doi:10.1136/gutjnl-2014-308430 · Cited by 206
Cholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-alcoholic Steatohepatitis
Wang, X., Cai, B., Yang, X., Sonubi, O. O., Zheng, Z., Ramakrishnan, R., Shi, H., Valenti, L., Pajvani, U. B., Sandhu, J., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.03.010 · Cited by 204
Che, L., Chi, W., Qiao, Y., Zhang, J., Song, X., Liu, Y., Li, L., Jia, J., Pilo, M. G., Wang, J., et al. (2020) · Gut · doi:10.1136/gutjnl-2018-317581 · Cited by 203
Kotronen, A., Velagapudi, V. R., Yetukuri, L., Westerbacka, J., Bergholm, R., Ekroos, K., Makkonen, J., Taskinen, M.-R., Orešič, M., & Yki-Järvinen, H. (2009) · Diabetologia · doi:10.1007/s00125-009-1282-2 · Cited by 198
Derdak, Z., Villegas, K. A., Harb, R., Wu, A. M., Sousa, A., & Wands, J. R. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.042 · Cited by 193
ROS-Mediated p53 Induction of Lpin1 Regulates Fatty Acid Oxidation in Response to Nutritional Stress
Assaily, W., Rubinger, D. A., Wheaton, K., Lin, Y., Ma, W., Xuan, W., Brown-Endres, L., Tsuchihara, K., Mak, T. W., & Benchimol, S. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.038 · Cited by 192
Kowdley, K. V., Vuppalanchi, R., Levy, C., Floreani, A., Andreone, P., LaRusso, N. F., Shrestha, R., Trotter, J., Goldberg, D., Rushbrook, S., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.02.033 · Cited by 192
Generation of Specific Deoxynojirimycin-type Inhibitors of the Non-lysosomal Glucosylceramidase
Overkleeft, H. S., Renkema, G. H., Neele, J., Vianello, P., Hung, I. O., Strijland, A., van der Burg, A. M., Koomen, G.-J., Pandit, U. K., & Aerts, J. M. F. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26522 · Cited by 186
Proteomic and Lipidomic Signatures of Lipid Metabolism in NASH-Associated Hepatocellular Carcinoma
Muir, K., Hazim, A., He, Y., Peyressatre, M., Kim, D.-Y., Song, X., & Beretta, L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3797 · Cited by 183
Lim, K., Han, C., Dai, Y., Shen, M., & Wu, T. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0551 · Cited by 182
Banales, J. M., Iñarrairaegui, M., Arbelaiz, A., Milkiewicz, P., Muntané, J., Muñoz‐Bellvis, L., La Casta, A., Gonzalez, L. M., Arretxe, E., Alonso, C., et al. (2019) · Hepatology · doi:10.1002/hep.30319 · Cited by 179
Mencarelli, A., Renga, B., Migliorati, M., Cipriani, S., Distrutti, E., Santucci, L., & Fiorucci, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901347 · Cited by 177 · cited 1×
“types and organs, including the gut,(151) hepatocytes,(152) hepatic stellate cells (HSCs)(152) and immune cells.(153) Conversely, a stepwise increase in plasma-conjugated BAs has been observed in the trajectory from healthy control to benign biliary disease, and further to CCA.”
BackgroundMa, M. K. F., Lau, E. Y. T., Leung, D. H. W., Lo, J., Ho, N. P. Y., Cheng, L. K. W., Ma, S., Lin, C. H., Copland, J. A., Ding, J., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.06.015 · Cited by 177
Ressom, H. W., Xiao, J. F., Tuli, L., Varghese, R. S., Zhou, B., Tsai, T., Ranjbar, M., Zhao, Y. C., Wang, J., Poto, C. D., et al. (2012) · Analytica Chimica Acta · doi:10.1016/j.aca.2012.07.013 · Cited by 173
Zhou, L., Wang, Q., Yin, P., Xing, W., Wu, Z., Chen, S., Lu, X., Zhang, Y., Lin, X., & Xu, G. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-5782-4 · Cited by 171
β-catenin-activated hepatocellular carcinomas are addicted to fatty acids
Senni, N., Savall, M., Granados, D. C., Alves‐Guerra, M., Sartor, C., Lagoutte, I., Gougèlet, A., Terris, B., Gilgenkrantz, H., Perret, C., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315448 · Cited by 171
Doege, H., Grimm, D., Falcon, A., Tsang, B., Storm, T. A., Xu, H., Ortegon, A. M., Kazantzis, M., Kay, M. A., & Stahl, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803510200 · Cited by 169
Seppala-Lindroos, A. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3023 · Cited by 168
Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids
Orešič, M., Hyötyläinen, T., Kotronen, A., Gopalacharyulu, P., Nygren, H., Arola, J., Castillo, S., Mattila, I., Hakkarainen, A., Borra, R. J. H., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2981-2 · Cited by 167
Britten, C. D., Garrett-Mayer, E., Chin, S. H., Shirai, K., Ogretmen, B., Bentz, T. A., Brisendine, A., Anderton, K., Cusack, S. L., Maines, L. W., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2363 · Cited by 167
Weylandt, K. H., Krause, L. F., Gomolka, B., Chiu, C., Bilal, S., Nadolny, A., Waechter, S. F., Fischer, A., Rothe, M., & Kang, J. X. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr049 · Cited by 165
Mayo, R., Crespo, J., Martínez‐Arranz, I., Banales, J. M., Arias, M., Mincholé, I., Aller de la Fuente, R., Jimenez‐Agüero, R., Alonso, C., de Luis, D. A., et al. (2018) · Hepatology Communications · doi:10.1002/hep4.1188 · Cited by 164
Alkhouri, N., Lawitz, E., Noureddin, M., DeFronzo, R., & Shulman, G. I. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1668374 · Cited by 162
Gao, R., Cheng, J., Fan, C., Shi, X., Cao, Y., Sun, B. H., Ding, H., Hu, C., Dong, F., & Yan, X. (2015) · Scientific Reports · doi:10.1038/srep18175 · Cited by 162
A NEW DEFICIENCY DISEASE PRODUCED BY THE RIGID EXCLUSION OF FAT FROM THE DIET
BURR, G. O., & BURR., M. M. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1973.tb06008.x · Cited by 161
Pockros, P. J., Fuchs, M., Freilich, B., Schiff, E., Kohli, A., Lawitz, E. J., Hellstern, P. A., Owens‐Grillo, J., Van Biene, C., Shringarpure, R., et al. (2019) · Liver International · doi:10.1111/liv.14209 · Cited by 160
Gouw, A. M., Eberlin, L. S., Margulis, K., Sullivan, D. K., Toal, G. G., Tong, L., Zare, R. N., & Felsher, D. W. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617709114 · Cited by 159
Lipid Remodeling in Hepatocyte Proliferation and Hepatocellular Carcinoma
Hall, Z., Chiarugi, D., Charidemou, E., Leslie, J., Scott, E., Pellegrinet, L., Allison, M., Mocciaro, G., Anstee, Q. M., Evan, G. I., et al. (2021) · Hepatology · doi:10.1002/hep.31391 · Cited by 159
Trottier, J., Bialek, A. P., Caron, P., Straka, R. J., Heathcote, J., Milkiewicz, P., & Barbier, O. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2011.10.025 · Cited by 158
Gu, L., Zhu, Y., Lin, X., Tan, X., Lu, B., & Li, Y. (2020) · Oncogene · doi:10.1038/s41388-020-1156-0 · Cited by 156
The Lipid Maps Initiative in Lipidomics
Schmelzer, K. R., Fahy, E., Subramaniam, S., & Dennis, E. A. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)32007-7 · Cited by 155
Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans
Li, L., Pilo, G., Li, X., Cigliano, A., Latte, G., Che, L., Joseph, C., Mela, M., Wang, C., Jiang, L., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.004 · Cited by 153
Noninvasive tracing of Krebs cycle metabolism in liver.
Magnusson, I., Schumann, W. C., Bartsch, G. E., Chandramouli, V., Kumaran, K., Wahren, J., & Landau, B. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89598-2 · Cited by 152
Wei, Q., Guo, P., Mu, K., Zhang, Y., Zhao, W., Huai, W., Qiu, Y., Li, T., Ma, X., Liu, Y., et al. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.63 · Cited by 152
Wang, M., Wu, H., Fu, G., Zhang, H., Zhou, X., Tang, L., Dong, L., Qin, C., Huang, S., Zhao, L., et al. (2015) · Hepatology · doi:10.1002/hep.28415 · Cited by 152
Zhang, X., Barraza, K. M., & Beauchamp, J. L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722323115 · Cited by 152
Brown, Z. J., Fu, Q., Ma, C., Kruhlak, M. J., Zhang, H., Luo, J., Heinrich, B., Yu, S. J., Zhang, Q., Wilson, A., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0687-6 · Cited by 152
Kaplan, D. E., Serper, M. A., Mehta, R., Fox, R., John, B., Aytaman, A., Baytarian, M., Hunt, K., Albrecht, J., Njei, B., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.026 · Cited by 145
Syed‐Abdul, M. M., Parks, E. J., Gaballah, A. H., Bingham, K., Hammoud, G. M., Kemble, G. W., BUCKLEY, D. I., McCulloch, W. F., & Manrique‐Acevedo, C. (2019) · Hepatology · doi:10.1002/hep.31000 · Cited by 141
Huang, C., Tsai, S., Wang, Y., Pan, M., Kao, J., & Way, T. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200800592 · Cited by 139
An integrated2H and13C NMR study of gluconeogenesis and TCA cycle flux in humans
Jones, J. G., Solomon, M. A., Cole, S., Sherry, A. D., & Malloy, C. R. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.4.e848 · Cited by 138
Ooi, G. J., Meikle, P. J., Huynh, K., Earnest, A., Roberts, S. K., Kemp, W., Parker, B. L., Brown, W., Burton, P., & Watt, M. J. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.04.013 · Cited by 137
Sphingolipids in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma: Ceramide Turnover
Simón, J., Ouro, A., Ala-Ibanibo, L., Presa, N., Delgado, T. C., & Martínez‐Chantar, M. L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010040 · Cited by 134
Harrison, S. A., Bashir, M. R., Lee, K.-J., Shim-Lopez, J., Lee, J. W. J., Wagner, B. L., Smith, N. D., Chen, H. C., & Lawitz, E. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.01.047 · Cited by 132
Merkel, M., Weinstock, P. H., Chajek‐Shaul, T., Radner, H., Yin, B., Breslow, J. L., & Goldberg, I. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2912 · Cited by 130
Liu, G., Kuang, S., Cao, R., Wang, J., Peng, Q., & Sun, C. (2019) · The FASEB Journal · doi:10.1096/fj.201802619rr · Cited by 129
Ma, A. P. Y., Yeung, C. L. S., Tey, S. K., Mao, X., Wong, S. W. K., Ng, T. H., Ko, F. C. F., Kwong, E. M. L., Tang, A. H. N., Ng, I. O., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3944 · Cited by 129
Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC
Sydor, S., Best, J., Messerschmidt, I., Manka, P., Vilchez-Vargas, R., Brodesser, S., Lucas, C., Wegehaupt, A., Wenning, C., Aßmuth, S., et al. (2020) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000131 · Cited by 127
Dasarathy, S., Yang, Y., McCullough, A. J., Marczewski, S., Bennett, C., & Kalhan, S. C. (2011) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328345c8c7 · Cited by 124
Yin, F., Feng, F., Wang, L., Wang, X., Li, Z., & Cao, Y. W. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1884-7 · Cited by 123
Zeng, Y., Yao, X., Chen, L., Yan, Z., Liu, J., Zhang, Y., Feng, T., Wu, J., & Liu, X. (2016) · Oncotarget · doi:10.18632/oncotarget.11450 · Cited by 122
Stiede, K., Miao, W., Blanchette, H., Beysen, C., Harriman, G. C. B., Harwood, H. J., Kelley, H., Kapeller, R., Schmalbach, T., & Westlin, W. (2017) · Hepatology · doi:10.1002/hep.29246 · Cited by 117
Jouve, J., Lecomte, T., Bouché, O., Barbier, E., Akouz, F. K., Riachi, G., Khac, E. N., Ollivier‐Hourmand, I., Debette‐Gratien, M., Faroux, R., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.04.021 · Cited by 117
The role of Wnt signaling pathway in tumor metabolic reprogramming
Mo, Y., Wang, Y., Zhang, L., Yang, L., Zhou, M., Li, X., Li, Y., Li, G., Zeng, Z., Xiong, W., et al. (2019) · Journal of Cancer · doi:10.7150/jca.31166 · Cited by 113
Ma, X., Sun, Y., Wang, B., Shen, M., Zhou, Y., Chen, J., Hu, B., Gong, Z., Zhang, X., Cao, Y., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5963-z · Cited by 113
The gut microbiome-bile acid axis in hepatocarcinogenesis
Wu, L., Feng, J., Li, J., Yu, Q., Ji, J., Wu, J., Dai, W., & Guo, C. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111036 · Cited by 113
Beljanski, V., Lewis, C. S., & Smith, C. D. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.5.14677 · Cited by 112
Huang, G.-M., Jiang, Q., Cai, C., Qu, M., & Shen, W. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.12.036 · Cited by 112
Chow, J. D. Y., Lawrence, R., Healy, M. E., Dominy, J. E., Liao, J. A., Breen, D. S., Byrne, F. L., Kenwood, B. M., Lackner, C., Okutsu, S., et al. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.02.004 · Cited by 112
Valenzuela, R., Espinosa, A., Gonzalez‐Mañán, D., D’Espessailles, A., Fernández, V., Videla, L. A., & Tapia, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046400 · Cited by 108
Lee, Y., Kim, J. H., Kim, S. R., Jin, H. Y., Rhee, E., Cho, Y. M., & Lee, B. (2016) · Journal of Korean Medical Science · doi:10.3346/jkms.2017.32.1.60 · Cited by 106
Li, L., Che, L., Tharp, K. M., Park, H., Pilo, M. G., Cao, D., Cigliano, A., Latte, G., Xu, Z., Ribback, S., et al. (2016) · Hepatology · doi:10.1002/hep.28508 · Cited by 105
C16-ceramide is a natural regulatory ligand of p53 in cellular stress response
Fekry, B., Jeffries, K. A., Esmaeilniakooshkghazi, A., Szulc, Z. M., Knagge, K. J., Kirchner, D. R., Horita, D. A., Krupenko, S. A., & Krupenko, N. I. (2018) · Nature Communications · doi:10.1038/s41467-018-06650-y · Cited by 103
Lerat, H., Kammoun, H. L., Hainault, I., Mérour, E., Higgs, M. R., Callens, C., Lemon, S. M., Foufelle, F., & Pawlotsky, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.019810 · Cited by 101
Cassim, S., Raymond, V., Assadzadeh, L. D., Lapierre, P., & Bilodeau, M. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1460023 · Cited by 101
Holt, H., Wild, S. H., Wood, P. J., Zhang, J.-L., Darekar, A., Dewbury, K. C., Poole, R., Holt, R. I. G., Phillips, D. I., & Byrne, C. D. (2005) · Diabetologia · doi:10.1007/s00125-005-0070-x · Cited by 100
Kemp, C. J., Leary, C., & Drinkwater, N. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7505 · Cited by 99
Nelson, M. E., Lahiri, S., Chow, J. D. Y., Byrne, F. L., Hargett, S. R., Breen, D. S., Olzomer, E. M., Wu, L. E., Cooney, G. J., Turner, N. A., et al. (2017) · Nature Communications · doi:10.1038/ncomms14689 · Cited by 98
Caussy, C., Ajmera, V. H., Puri, P., Hsu, C. L., Bassirian, S., Mgdsyan, M., Singh, S., Faulkner, C., Valasek, M. A., Rizo, E., et al. (2018) · Gut · doi:10.1136/gutjnl-2018-317584 · Cited by 98
Evidence for regulated monoacylglycerol acyltransferase expression and activity in human liver
Hall, A. M., Kou, K., Chen, Z., Pietka, T., Kumar, M., Korenblat, K., Lee, K., Ahn, K., Fabbrini, E., Klein, S., et al. (2012) · Journal of Lipid Research · doi:10.1194/jlr.p025536 · Cited by 97
Lewińska, M., Santos‐Laso, Á., Arretxe, E., Alonso, C., Zhuravleva, E., Jiménez-Agüero, R., Eizaguirre, E., Pareja, M. J., Romero‐Gómez, M., Arrese, M. A., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103661 · Cited by 97
Self-citationSchuster, S., Johnson, C. D., Hennebelle, M., Holtmann, T. M., Taha, A. Y., Kirpich, I., Eguchi, A., Ramsden, C. E., Papouchado, B. G., McClain, C. J., et al. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m083741 · Cited by 95
Falvella, F. S., Pascale, R. M., Gariboldi, M., Manenti, G., Miglio, M. R. D., Simile, M. M., Dragani, T. A., & Feo, F. (2002) · Carcinogenesis · doi:10.1093/carcin/23.11.1933 · Cited by 93
Impact of bile acids on the growth of human cholangiocarcinoma via FXR
Dai, J., Wang, H., Shi, Y. H., Dong, Y., Zhang, Y., & Wang, J. (2011) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-4-41 · Cited by 93
Complex lipid metabolic remodeling is required for efficient hepatitis C virus replication
Hofmann, S., Krajewski, M. P., Scherer, C., Scholz, V., Mordhorst, V., Truschow, P., Schöbel, A., Reimer, R., Schwudke, D., & Herker, E. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.06.002 · Cited by 93
Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis
Bell, L. N., Wulff, J. E., Comerford, M., Vuppalanchi, R., & Chalasani, N. (2014) · Liver International · doi:10.1111/liv.12680 · Cited by 91
José, C., Hébert-Chatelain, É., Bellancé, N., Larendra, A., Melser, S., Nouette‐Gaulain, K., & Rossignol, R. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.12.002 · Cited by 91
Grammatikos, G., Schoell, N., Ferreirós, N., Bon, D., Herrmann, E. M., Farnik, H., Köberle, V., Piiper, A., Zeuzem, S., Kronenberger, B., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7741 · Cited by 91
ACADL plays a tumor-suppressor role by targeting Hippo/YAP signaling in hepatocellular carcinoma
Zhao, X., Qin, W., Jiang, Y., Yang, Z., Yuan, B., Dai, R., Shen, H., Chen, Y., Fu, J., & Wang, H. (2020) · npj Precision Oncology · doi:10.1038/s41698-020-0111-4 · Cited by 90
Ceramide and polyunsaturated phospholipids are strongly reduced in human hepatocellular carcinoma
Krautbauer, S., Haberl, E. M., Rein‐Fischboeck, L., Pohl, R., Weiß, T. S., Sigrüener, A., Aslanidis, C., Liebisch, G., & Buechler, C. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.08.014 · Cited by 88
Chen, Z., Chen, L., Sun, B., Liu, D., He, Y., Qi, L., Li, G., Han, Z., Zhan, L., Zhang, S., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101230 · Cited by 86
Westerbacka, J., Kotronen, A., Fielding, B. A., Wahren, J., Hodson, L., Perttilä, J., Seppänen‐Laakso, T., Suortti, T., Arola, J. T., Hultcrantz, R. W., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.064 · Cited by 84
Zhou, S., Gordon, R. E., Bradbury, M., Stump, D. D., Kiang, C. L., & Berk, P. D. (1998) · Hepatology · doi:10.1002/hep.510270423 · Cited by 84
McGlynn, K. A., Sahasrabuddhe, V. V., Campbell, P. T., Graubard, B. I., Chen, J., Schwartz, L. M., Petrick, J. L., Alavanja, M. C. R., Andreotti, G., Boggs, D. A., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.58 · Cited by 83
Zhou, L., Ding, L., Yin, P., Lu, X., Wang, X., Niu, J., Gao, P., & Xu, G. (2012) · Journal of Proteome Research · doi:10.1021/pr300683a · Cited by 82
Hepatocyte-specific, PPARγ-regulated mechanisms to promote steatosis in adult mice
Greenstein, A. W., Majumdar, N., Yang, P., Subbaiah, P. V., Kineman, R. D., & Córdoba‐Chacón, J. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0447 · Cited by 82
Thomas, C. E., Luu, H. N., Wang, R., Xie, G., Adams‐Haduch, J. M., Jin, A., Koh, W., Jia, W. P., Behari, J., & Yuan, J. (2021) · Cancers · doi:10.3390/cancers13112648 · Cited by 82
Wang, M., Zhang, X., Feng, K., He, C., Li, P., Yuanjia, H., Su, H., & Wan, J. (2016) · Scientific Reports · doi:10.1038/srep26826 · Cited by 80
Evidence of aberrant lipid metabolism in hepatitis C and hepatocellular carcinoma
Wu, J.-M., Skill, N. J., & Maluccio, M. A. (2010) · HPB · doi:10.1111/j.1477-2574.2010.00207.x · Cited by 79
Insulin Regulates Hepatic Triglyceride Secretion and Lipid Content via Signaling in the Brain
Scherer, T., Lindtner, C., O’Hare, J., Hackl, M. T., Zieliński, E., Freudenthaler, A., Baumgartner-Parzer, S. M., Tödter, K., Heeren, J., Krššák, M., et al. (2016) · Diabetes · doi:10.2337/db15-1552 · Cited by 79
Cui, M., Xiao, Z., Sun, B., Wang, Y., Zheng, M., Ye, L., & Zhang, X. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.068 · Cited by 78
Jeyapal, S., Kona, S. R., Mullapudi, S. V., Putcha, U. K., Gurumurthy, P., & Ibrahim, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-29222-y · Cited by 78
S1P Stimulates Proliferation by Upregulating CTGF Expression through S1PR2-Mediated YAP Activation
Cheng, J., Wang, E. Y., Yi, Y., Thakur, A., Tsai, S., & Hoodless, P. A. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0681 · Cited by 76
Merrill, C. L. (2002) · Toxicological Sciences · doi:10.1093/toxsci/68.1.93 · Cited by 75
Kim, W. K., Kim, B. G., Lee, J. S., Lee, C. K., Yeon, J. E., Chang, M. S., Kim, J. H., Kim, H., Yi, S., Lee, J., et al. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13981 · Cited by 75
E2F1 and E2F2-Mediated Repression of CPT2 Establishes a Lipid-Rich Tumor-Promoting Environment
González‐Romero, F., Mestre, D., Aurrekoetxea, I., O’Rourke, C. J., Andersen, J. B., Woodhoo, A., Tamayo-Caro, M., Varela‐Rey, M., Palomo-Irigoyen, M., Gómez‐Santos, B., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2052 · Cited by 75
Self-citationHypoxia-inducible lipid droplet-associated induces DGAT1 and promotes lipid storage in hepatocytes
Rodriguez, M. A. D. L. R., Deng, L., Gemmink, A., van Weeghel, M., Aoun, M. L., Warnecke, C., Singh, R., Borst, J. W., & Kersten, S. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101168 · Cited by 74
Serum lipid profile as a marker of liver impairment in hepatitis B Cirrhosis patients
Arain, S. Q., Talpur, F. N., Channa, N. A., Ali, M. S., & Afridi, H. I. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0437-2 · Cited by 73
Han, Q., Chen, C.-A., Yang, W. K., Liang, D., Lv, H., Lv, G., Zong, Q.-N., & Wang, H. (2020) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2020.05.010 · Cited by 73
Su, Y., Feng, Y., Wu, H., Huang, Y.-S., Tung, C.-L., Wu, P., Chang, C., Shiau, A., & Wu, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-24633-3 · Cited by 70
Lin, H., Chen, Y., Hsu, W., Yang, C.-W., Kao, C., & Tsai, T. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0001 · Cited by 69
JNK-mediated disruption of bile acid homeostasis promotes intrahepatic cholangiocarcinoma
Manieri, E., Folgueira, C., Rodríguez, M. E., Leiva‐Vega, L., Esteban-Lafuente, L., Chen, C., Cubero, F. J., Barrett, T., Cavanagh, J., Seruggia, D., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002672117 · Cited by 69
Kawata, S., Takaishi, K., Nagase, T., et al. (1990) · PubMed · Cited by 68
Cited by
Metabolic reprogramming in the tumor microenvironment of liver cancer
Lin, J., Rao, D., Zhang, M., & Gao, Q. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01527-8 · Cited by 251
“High-cholesterol diets induce HCC in mice, partly through dysregulation of metabolism and calcium signaling [55–57].”
BackgroundKohlhepp, M. S., Liu, H., Tacke, F., & Guillot, A. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1129831 · Cited by 27
Xiao, M.-Y., Pei, W.-J., Li, S., Li, F.-F., Xie, P., Luo, H.-T., Hyun Yoo, H., & Piao, X.-L. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107539 · Cited by 26
Metadata
- Authors
- Paul, B., Lewinska, M., & Andersen, J. B.
- Venue
- JHEP Reports
- Publisher
- Elsevier BV
- Published
- 2022-06
- Volume
- 4
- Issue
- 6
- Pages
- 100479
- ISSN
- 2589-5559 (ISSN-L)
- OpenAlex
- W4220874523
- Cited by
- 308
- References
- 296
- FWCI
- 23.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.